Radiotherapy Market By Key Manufacturers, By Product Type (External Beam Therapy, Internal Beam Therapy), By Type (External Beam, Internal Beam, Systemic), By End-User (Hospitals, Independent Radiotherapy Centers) and By Region (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) – Global Outlook to 2026
Report ID: 58674 | Jan 2019 | No. of Pages: 120 |
Covid-19 Impact Analysis & Forecast
The global Radiotherapy market was valued at USD 6.92 Billion in 2018 and is projected is to exhibit 6.0% CAGR during the forecast period. The market is expected to reach USD 11.01 Billion by 2026. Radiotherapy, also known as radiation therapy (abbreviated also as RT, RTx, or XRT) is a treatment used to kill cancer cells or shrink tumors using high doses of radiation in the treatment of cancer.
Radiotherapy Market Dynamics
The global Radiotherapy market is driven owing to the significant rise in cancer cases across the globe coupled with technological advancement in the field of radiation therapy. In addition, demands from emerging markets, growing private and government investments to suffice rising demand for cancer treatment, and the enhanced reimbursement scenarios across the healthcare sector worldwide act as more positive driving factors for the global radiotherapy market during the forecast period.
Radiotherapy Market Insight
Asia Pacific dominates the global Radiotherapy market owing to rising per capita incomes, improving healthcare and medical infrastructure, and huge population base of which a percent of people suffering from some or the other diseases that requires radiotherapy treatment. North America and Europe also occupy a considerable share of the market owing to existing good medical infrastructure and usage of radiotherapy treatment for required diseases. Latin America radiotherapy market is also analyzed to grow at a good rate during the forecast period.
Radiotherapy Market Segmentation
The global Radiotherapy market is segmented into product type, type, end-user, and region. On the basis of the product type the market is further bifurcated into external beam radiotherapy and internal beam radiotherapy. By type, the market is classified into external beam, internal beam, and systemic. On the basis of end-user, the global Radiotherapy market is segmented into hospitals and independent radiotherapy centers. Based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Radiotherapy Market Competitive Landscape
The major players associated with the global Radiotherapy market are Varian Medical Systems, Inc, Elekta AB, Accuray Incorporated, Ion Beam Applications SA, ViewRay, Inc., IsoRay Medical, Inc., Hitachi Ltd., Panacea Medical Technologies Pvt. Ltd., Provision Healthcare, and Mevion Medical Systems, Inc. among others.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Radiotherapy Market, By Product Type
5.1. Radiotherapy Market, by Product Type, 2018-2026
5.1.1. External Beam Therapy
5.1.2. Internal Beam Therapy
Chapter 6. Radiotherapy Market, By Type
6.1. Radiotherapy Market, by Type, 2018-2026
6.1.1. External Beam
6.1.2. Internal Beam
6.1.3. Systemic
Chapter 7. Radiotherapy Market, By End-user
7.1. Radiotherapy Market, by End-user, 2018-2026
7.1.1. Hospitals
7.1.2. Independent Radiotherapy Centers
Chapter 8. Radiotherapy Market, By Region
8.1. Radiotherapy Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APAC
Chapter 9. Competitive Landscape
9.1.1. Key Strategies Adopted by Players
9.1.2. Market Share/Positioning Analysis
Chapter 10. Company Profiles
10.1. Varian Medical Systems Inc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Elekta AB
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Accuray Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Ion Beam Applications SA
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. ViewRay Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IsoRay Medical Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Hitachi Ltd.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Provision Healthcare
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Panacea Medical Technologies
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Mevion Medical Systems
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Varian Medical Systems Inc
Elekta AB
Accuray Incorporated
Ion Beam Applications SA
ViewRay Inc.
IsoRay Medical Inc.
Hitachi Ltd.
Panacea Medical Technologies Pvt. Ltd.
Provision Healthcare
Mevion Medical Systems Inc

Select License Type
USD $4250
USD $6250
Connect With Us

+1-707-633-0404